| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/07/1993 | EP0549702A1 Uses of recombinant colony stimulating factor-1 |
| 07/07/1993 | EP0549621A1 New leukotriene-b 4? antagonists, process for producing the same and their use as medicinal drugs. |
| 07/07/1993 | EP0538330A4 Beta-alethine use in cell culture and therapy |
| 07/07/1993 | EP0412110B1 Novel vitamin d analogues |
| 07/07/1993 | CN1073936A Alpha-substituted benzenemethanamine derivatives |
| 07/07/1993 | CN1073878A Expression of specific immunogens using viral antigens |
| 07/06/1993 | US5225559 Diarylmethoxypiperidine derivatives |
| 07/06/1993 | US5225438 Aryl derivatives |
| 07/06/1993 | US5225422 Pyridine compounds which are useful as leukotriene b4 antagonist |
| 07/06/1993 | US5225420 Use of tetrahydrothienopyridine derivatives as angiogenesis inhibitors |
| 07/06/1993 | US5225193 Bordetella toxin peptides and vaccines |
| 07/06/1993 | CA1319931C Antiviral antitumor antimetastatic immune system enhancing nucleosides and nucleotides |
| 07/01/1993 | CA2086442A1 N-acyl derivatives of aminoalcohols active as local autocoidis and useful in the therapy of autoimmune processes |
| 07/01/1993 | CA2086441A1 N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having meuroimmunogenic origin |
| 07/01/1993 | CA2086357A1 N-[3-[2-(1h-imidazol-1-yl) ethoxy]phenyl]-4-(2-thienyl) -2-pyrimidinamine and pharmacologically acceptable salts |
| 06/30/1993 | EP0549074A1 Adjuvants |
| 06/30/1993 | EP0548883A1 Substituted pyridine-N-oxides, process for their preparation and their use as medicines |
| 06/30/1993 | EP0548370A1 Drug for preventing and/or treating allergic disease |
| 06/30/1993 | EP0548226A1 Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof |
| 06/30/1993 | EP0548214A1 EXPRESSION OF MACROPHAGE INDUCIBLE PROTEINS (MIPs) IN YEAST CELLS |
| 06/30/1993 | EP0548200A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 06/30/1993 | CN1073683A Organic salts of N,N'-diacetyl cystine |
| 06/30/1993 | CN1073677A 20-methyl-substituted vitamin D-derivatives |
| 06/29/1993 | US5223533 Antiallergens, antiinflammatory, sunscreen agents |
| 06/29/1993 | US5223517 Heterocyclically substituted cycloalkano[b]-indolesulphonamides |
| 06/29/1993 | US5223504 Xanthine compounds and compositions, and methods of using them |
| 06/29/1993 | US5223426 Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor |
| 06/29/1993 | US5223425 DNA sequence which codes serine protease for diagnosis and/or treatment of obesity or metabolic defects |
| 06/29/1993 | CA1319607C Antithrombotic pharmaceutical preparation and process for preparing same |
| 06/25/1993 | CA2085954A1 Substituted pyridine n-oxides, processes for their preparation, and their use |
| 06/24/1993 | WO1993012232A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
| 06/24/1993 | WO1993012221A1 Association between a human immunodeficiency virus-related retrovirus and autoimmune disease |
| 06/24/1993 | WO1993012145A1 Pva or peg conjugates of peptides for epitope-specific immunosuppression |
| 06/24/1993 | WO1993012125A1 Phosphoric acid ester of heteroring compound as medicament |
| 06/24/1993 | WO1993012108A1 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring |
| 06/24/1993 | WO1993012107A1 Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring |
| 06/24/1993 | WO1993012095A1 Quinazolinone antianginal agents |
| 06/24/1993 | WO1993012081A1 20-methyl-substituted vitamin d derivates |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/24/1993 | CA2125396A1 Reactive neutralizing human anti-gp 120 recombinant antibody, dna coding the same and use thereof |
| 06/23/1993 | EP0548024A2 Aminosulphonic acid derivatives and process for their preparation |
| 06/23/1993 | EP0547705A1 Pharmacologically active tricyclic benzotriazepine derivatives |
| 06/23/1993 | EP0547558A1 Use of aminoguanidine for the manufacture of a medicament for inhibiting nitric oxide formation |
| 06/23/1993 | EP0547517A1 Pyridyl derivatives, medicines containing these compounds and processes for their preparation |
| 06/23/1993 | EP0547229A1 External preparation containing cyclosporin |
| 06/23/1993 | EP0547163A1 Protein polyligands joined to a stable protein core |
| 06/23/1993 | EP0547148A1 Naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents |
| 06/23/1993 | EP0547076A1 Cd58-specific monoclonal antibodies and their use |
| 06/23/1993 | EP0348527B1 Antiallergic eye drop |
| 06/23/1993 | CN1073443A O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity |
| 06/23/1993 | CN1073437A Pharmaceutical compounds |
| 06/23/1993 | CN1073357A Tocotrienols and tocotrienol-like compounds and methods for their use |
| 06/23/1993 | CN1021325C Process for preparing ethynylphenyl-containing retinoic acid derivatives |
| 06/22/1993 | US5221789 Interferon-gamma receptor fragment and its production |
| 06/22/1993 | US5221740 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 06/22/1993 | US5221678 Cardiovascular disorders, antiinflammatory agents, antiallergens |
| 06/22/1993 | US5221677 For treating diseases mediated by leukotrienes |
| 06/22/1993 | CA1319322C Azelastine-containing medicaments for application in the nose and/or eye |
| 06/20/1993 | CA2085715A1 Aminosulfonic acid derivatives and processes for their preparation |
| 06/19/1993 | CA2085705A1 Pharmacologically active tricyclic derivatives |
| 06/17/1993 | DE4141746A1 20-methyl-substituierte vitamin d-derivate 20-methyl-substituted vitamin d derivatives |
| 06/17/1993 | CA2085399A1 Method for inhibiting nitric oxide formation |
| 06/16/1993 | EP0546870A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 06/16/1993 | EP0546787A2 Expression of specific immunogens using viral antigens |
| 06/16/1993 | EP0546096A1 Macrophage activating factor from vitamin d binding protein |
| 06/16/1993 | EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 06/16/1993 | CN1021223C Process for 5-lipoxygense inhibiting 4-(4-phenyl-1-pip-erazing 1) phenols |
| 06/15/1993 | US5220059 An N-amino-, hydroxy or thiocarbonyl or thiocarbonyl, N-hydroxyaminoalkylene derivative |
| 06/15/1993 | US5219864 Thienopyridine derivatives |
| 06/14/1993 | CA2085212A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 06/13/1993 | CA2085142A1 Stabilized pharmaceutical composition of non glycosyled recombinant human il2 in reduced form and preparation process therefore |
| 06/12/1993 | CA2084180A1 Expression of specific immunogens using viral antigens |
| 06/10/1993 | WO1993011237A1 Cdr grafted humanised chimeric t-cell antibodies |
| 06/10/1993 | WO1993011234A1 Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
| 06/10/1993 | WO1993011130A1 Rapamycin derivative and its medicinal use |
| 06/10/1993 | WO1993011105A1 Leukotriene-b4 derivatives, process for preparing the same and medicaments |
| 06/10/1993 | WO1993011104A1 Organic salts of n, n'-diacetyl cystine |
| 06/10/1993 | WO1993010817A1 CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS |
| 06/10/1993 | WO1993010816A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses |
| 06/10/1993 | WO1993010802A1 Aqueous synthetic organ extracts |
| 06/10/1993 | WO1993010796A1 Substituted lactose and lactosamine derivatives as cell adhesion inhibitors |
| 06/10/1993 | WO1993010791A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
| 06/10/1993 | WO1993010780A1 Heterocyclic-substituted pyridine compounds and uses |
| 06/10/1993 | WO1993010742A2 Chemical compounds, their preparation and use |
| 06/10/1993 | CA2124852A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
| 06/10/1993 | CA2124691A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses |
| 06/10/1993 | CA2124338A1 Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
| 06/10/1993 | CA2123516A1 Organic salts of n,n'-diacetyl cystine |
| 06/10/1993 | CA2122992A1 Leukotriene-b derivatives, process for preparing the same and medicaments |
| 06/09/1993 | EP0545413A1 Novel trans cyclopentanyl purine analogs useful as immunosuppressants |
| 06/09/1993 | EP0545171A1 Quinolylmethoxyphenyl acetic acid acylamides and ureas |
| 06/09/1993 | EP0545170A1 Quinolylmethoxyphenylacetamides |
| 06/09/1993 | EP0544668A1 -6-fluoro-9-(2,3-dideoxy-b-d-glycero-pentofuranosyl)-9h-purines and their use asantiviral agents |
| 06/09/1993 | CN1072843A Gel-type cosmetic composite |
| 06/08/1993 | US5217990 Antiallergens, antiinflammatory agents |
| 06/08/1993 | US5217978 Lipoxygenase inhibitors |
| 06/08/1993 | US5217969 Antiinflammatory, antiulcer agent |
| 06/04/1993 | CA2084162A1 Quinolylmethoxyphenyl-acetamides |
| 06/04/1993 | CA2084161A1 Quinolylmethoxyphenylacetic acid acylamides and ureas |
| 06/02/1993 | EP0543879A1 Macrocyclic compounds |